AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TAT Technologies Ltd.

Proxy Solicitation & Information Statement Oct 3, 2022

7072_rns_2022-10-03_1b0fb636-b8df-437a-817f-0a567a6d0b4b.pdf

Proxy Solicitation & Information Statement

Open in Viewer

Opens in native device viewer

TAT Technologies Ltd .

Gibori Israel 7, Netanya 4250407 IsraelTHIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF

DIRECTORS OF TAT TECHNOLOGIES LTD .

The undersigned, a shareholder of TAT Technologies Ltd. (the "Company"), an Israeli corporation, hereby appoints Adv. Idan Lidor, and Adv. Shachar Hananel or either of them, attorney or attorneys of the undersigned, as the attorney and proxy of the undersigned, with full power of substitution, for and in the name of the undersigned, to vote and otherwise act on behalf of the undersigned at the annual and special general meeting of shareholders of the Company to be held at the offices of Naschitz, Brandes, Amir & Co., Advocates, located at 5 Tuval Street, Tel-Aviv, Israel, on November 8, 2022 at 17:00 P.M. Israel time, or at any adjournment(s) or postponement(s) thereof (the "Meeting"), with respect to all of the ordinary shares, par value NIS 0.90, of the Company (the "Shares") which the undersigned would be entitled to vote, with all powers the undersigned would possess if personally present, provided said proxies are authorized and directed to vote as indicated with respect to the matter set forth below in this Proxy. Subject to applicable law and the rules of NASDAQ, in the absence of such instructions, the Shares represented by properly executed and received proxies will be voted "FOR" all of the proposed resolutions to be presented to the Meeting for which the Board of Directors recommends a "FOR" vote, other than Items 1 through 4 .

A shareholder's proxy card must be received by the Company no later than November 8, 2022, 13:00 P.M. Israel time, otherwise it shall not be valid at the Meeting.

This proxy also delegates, to the extent permitted by applicable law, discretionary authority to vote with respect to any other business which may properly come before the Meeting .

WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING, PLEASE COMPLETE, DATE AND SIGN THIS FORM OF PROXY AND MAIL THE PROXY PROMPTLY, ALONG WITH PROOF OF IDENTITY IN ACCORDANCE WITH THE COMPANY'S PROXY STATEMENT, IN THE ENCLOSED ENVELOPE IN ORDER TO ASSURE REPRESENTATION OF YOUR SHARES. NO POSTAGE NEED BE AFFIXED IF THE PROXY IS MAILED IN THE UNITED STATES .

PLEASE NOTE THAT YOU ARE REQUIRED TO INDICATE WITH RESPECT TO ITEM 4, WHETHER OR NOT YOU ARE THE CONTROLING SHAREHOLDER OF THE COMPANY OR WHETHER OR NOT YOU HAVE A PERSONAL INTEREST IN THE PROPOSALS SET FORTH IN ITEM 4. IF YOU FAIL TO NOTIFY US AS TO WHETHER OR NOT YOU ARE THE CONTROLING SHAREHOLDER OF THE COMPANY OR WHETHER OR NOT YOU HAVE A PERSONAL INTEREST WITH RESPECT TO ITEM 4, YOUR VOTE WILL NOT BE COUNTED WITH RESPECT TO SUCH ITEM.

Item No. 1 Approval of the re-appointment of Kesselman & Kesselman PwC Israel, a member of PricewaterhouseCoopers International Ltd., as our independent certified public accountants, effective as of the approval by the Meeting until our next Annual Meeting of Shareholders, and delegation to the Company's Board of Directors (or, the Audit Committee, if authorized by the Board of Directors) the authority to determine the accountants' remuneration in accordance with the volume and nature of their services.

Item No. 2 Approval of the re-election of each of Mr. Amos Malka and Roni Meninger (Independent Director), and the election of Gillon Beck to serve as Directors of the Company each to FOR AGAINST ABSTAIN

hold
office
until
our
next
Annual
Meeting
of
Shareholders
VOTE FOR EACH DIRECTOR SEPARATELY.
FOR AGAINST ABSTAIN
I. Mr. Amos Malka
II. Ms. Roni Meninger (Independent Director)
III. Mr. Gillon Beck
Item No. 3 Approval of the amended and restated Company's 2012
Stock Option Plan and Approval of 2022 Stock Option
Plan:
VOTE FOR EACH OPTION PLAN SEPARATELY FOR AGAINST ABSTAIN
3a. 2012 Stock Option Plan
3b. 2022 Stock Option Plan
Item No. 4 Approval of the amended compensation policy of the FOR AGAINST ABSTAIN
Company for an additional three (3) years.
By marking the "YES" box, you confirm that you are not a YES NO
"controlling shareholder" and do not have a "personal
interest" in the approval of Item No. 4. If you cannot make
such confirmation, please check the "NO" box (Please
note: If you do not mark either Yes or No, your shares will
not be voted for Item No. 4).

Shareholders entitled to notice of and to vote at the meeting shall be determined as of the close of business on October 11, 2022, the record date fixed by the Board of Directors for such purpose .

The signer hereby revokes all previous proxies given by the signer to vote at the annual general meeting or any adjournments thereof .

Signature _________________ Date __________, 2022 .

Please sign exactly as your name(s) appears on the Proxy. If held in joint tenancy, the shareholder named first in the Company's register must sign. Trustees, Administrators, etc., should include title and authority. Corporations should provide full name of corporation and title of authorized officer signing the Proxy. PLEASE BE SURE TO RETURN THE ENTIRE PROXY ALONG WITH PROOF OF IDENTITY AS DESCRIBED IN THE COMPANY'S PROXY STATEMENT .

Talk to a Data Expert

Have a question? We'll get back to you promptly.